The U.S. Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) as an add-on treatment for adults with lupus nephritis, a form of lupus marked by kidney damage. Lupus is an autoimmune ...

Once you receive a diagnosis of lupus, it is difficult to avoid its chronic impact. The disease stays on your mind and affects your perceptions and decisions. You may not be in a flare or “suffering,” ...

When you live with a chronic illness like lupus, you eventually learn that energy isn’t just something you “have” or “don’t have.” It’s sacred. It’s currency. And when it’s gone, it’s gone. Unlike a ...

A single infusion of the experimental cell therapy ADI-001 led to reductions in disease activity for seven lupus patients in a clinical trial, according to preliminary data announced by its developer ...

What is Gazyva for lupus nephritis? Gazyva (obinutuzumab) is a medication approved in the U.S. for adults with active lupus nephritis who are receiving standard therapies. The treatment is given via ...